| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |